XML 65 R44.htm IDEA: XBRL DOCUMENT v3.20.2
ACQUISITIONS - Purchase Price Allocation (Details) - USD ($)
$ in Thousands
May 20, 2020
Jun. 30, 2020
Dec. 31, 2019
Jan. 31, 2019
Business Acquisition [Line Items]        
Goodwill   $ 14,147 $ 0  
13% Senior Secured Notes due 2024 | Senior Notes        
Business Acquisition [Line Items]        
Interest rate 13.00%      
13% Senior Secured Notes due 2024 | Senior Notes | Zyla Life Sciences        
Business Acquisition [Line Items]        
Interest rate       13.00%
Zyla Life Sciences        
Business Acquisition [Line Items]        
Cash $ 7,585      
Accounts receivable 23,133      
Inventories 26,742      
Property and equipment 4,512      
Intangible assets 160,900      
Other assets 9,629      
Total identifiable assets acquired 232,501      
Accounts payable 21,574      
Accrued rebates, returns and discounts 33,254      
Other accrued liabilities 15,434      
Contingent consideration 29,400      
Debt 111,900      
Total liabilities assumed 211,562      
Net identifiable assets acquired 20,939      
Goodwill 14,147      
Net assets acquired 35,086      
Zyla Life Sciences | Promissory note        
Business Acquisition [Line Items]        
Debt 3,000      
Repayment of debt 3,000      
Zyla Life Sciences | Credit agreement        
Business Acquisition [Line Items]        
Debt 10,000      
Repayment of debt 10,000      
Zyla Life Sciences | Series A-1 Notes | Senior Notes        
Business Acquisition [Line Items]        
Debt 50,000      
Zyla Life Sciences | Series A-2 Notes | Senior Notes        
Business Acquisition [Line Items]        
Debt 45,000      
Zyla Life Sciences | Royalty rights obligation | Senior Notes        
Business Acquisition [Line Items]        
Debt $ 3,900